Zentaris GmbH
www.zentaris.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zentaris GmbH
Sanofi Abandons Oral SERD Breast Cancer Drug As Pipeline Woes Mount
Bookmark
-
News
The Paris-headquartered company has thrown in the towel on its oral SERD, leaving Roche, Eli Lilly and AstraZeneca to pursue Menarini in the field.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
Advertisement
Advertisement
Zentaris GmbH
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice